Search Results

Centrus Energy to Supply HALEU Fuel to Antares Nuclear, Enabling Micro Nuclear Reactor Applications for Military and Space

U.S. nuclear fuel supplier Centrus Energy has signed a multi-year contract with advanced microreactor developer Antares Nuclear, under which Centrus will supply high-assay low-enriched uranium (HALEU) to Antares. This agreement is expected to expand the application scenarios of micro nuclear reactors to locations where traditional power sources are difficult to use, such as military facilities and space environments. As part of the agreement, Antares Nuclear will make advance payments to support Centrus in expanding HALEU production capacity in the United States. Compared with conventional low-enriched uranium, HALEU contains more uranium-235, with an enrichment level above 5% but below 20%. This new type of fuel can support smaller, higher-energy-density reac...

2026-09-18

Microstructure Imaging's MICSI-PET Software Receives FDA Clearance to Enhance Neurological PET Imaging Using MRI

Microstructure Imaging's software platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The platform is designed to enhance neurological positron emission tomography (PET) images using structural magnetic resonance imaging (MRI). The software, called MICSI-PET, can denoise and super-resolve PET images using MRI guidance while preserving quantitative PET information. It supports PET exams for amyloid, Tau, and FDG (fluorodeoxyglucose), and can provide automated Centiloid measurements for amyloid imaging and CenTauR measurements for Tau imaging....

2026-09-18

Curium's Lutetium-177 Injection Approved by FDA for Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Radiopharmaceutical company Curium recently announced that its developed lutetium-177 (Lu-177) dotatate injection (trade name: Bexlutry) has received formal approval from the U.S. Food and Drug Administration (FDA). The drug is indicated for the treatment of somatostatin receptor-positive adult gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The specific indication scope includes various neuroendocrine tumors occurring in the adult foregut, midgut, and hindgut. Bexlutry is an advanced radioligand therapy whose mechanism of action lies in its ability to specifically bind to somatostatin receptors highly expressed on the surface of such tumors. Through this precise binding, the drug can deliver...

2026-09-16

Core Makeup Tank for Xudabao Nuclear Power Plant Unit 2 Arrives at Project Site

On September 14, the core makeup tank for Xudabao Nuclear Power Plant Unit 2 arrived at the Xudabao Nuclear Power Project site. The core makeup tank is an important passive engineered safety feature of the reactor coolant system and a major large-scale equipment on the construction path of the reactor building. During the manufacturing of this equipment, Liaoning Nuclear Power cooperated with China Nuclear Power Engineering Co., Ltd. by stationing personnel at the factory for full-process coordination, implementing dynamic control of equipment quality and manufacturing progress through "daily tracking and weekly assessment," and ensuring the smooth completion and on-schedule delivery of the core makeup tank for Unit 2 to the project site through measures such as optimizing production processes and implementing continuous operations, thus creating favorable conditions for the orderly commencement of main construction of the reactor building. Subsequently, the Equipment Procurement Department of Liaoning Nuclear Power...

2026-09-16

Germany to provide an additional 1 million euros to help address nuclear safety issues at the Zaporizhzhia NPP

Germany will provide an additional 1 million euros to help address nuclear safety issues at the Zaporizhzhia NPP. Recently, according to the German Federal Ministry for the Environment, the German government will provide an additional 1 million euros in aid to improve the safety level of Ukrainian nuclear power plants. Rita Schwarzelühr-Sutter, Parliamentary State Secretary at the German Federal Ministry for the Environment, is expected to formally announce this additional 1 million euros in funding on Tuesday at a meeting of the International Atomic Energy Agency (IAEA) in Vienna. Previously, Germany had cumulatively provided 7.3 million euros in financial support to the IAEA's nuclear safety and security work in Ukraine. Since...

2026-09-16

European Investment Bank to invest €40 million in Finnish small modular reactor company Steady Energy

The European Investment Bank will invest up to €40 million (about $46 million) in Finnish small modular reactor company Steady Energy. The company's LDR-50 reactor is specifically designed for district heating networks, and this is also the European Investment Bank's first investment in small modular reactor technology. The European Investment Bank is jointly owned by the 27 EU member states, and these member states do not have a consistent attitude toward nuclear energy. In the past, the bank usually avoided new nuclear power projects and invested only in projects related to nuclear safety, such as Chernobyl-related projects. However, over the past year or so, the European Investment Bank has provided loans for the refurbishment project of a reactor in Romania, as well as for the Tricastin...

2026-09-16

GE HealthCare Plans $1 Billion Acquisition of Radiopharmaceutical Company Sofie Biosciences

According to reports, healthcare giant GE HealthCare is in talks to acquire radiopharmaceutical company Sofie Biosciences for $1 billion. It is understood that this acquisition will be another major business move for GE HealthCare since its spin-off from General Electric Company in 2023. Previously, the company reached an agreement in March of this year to acquire software company Intelerad for $2.3 billion, aiming to enhance its cloud-based enterprise imaging service capabilities. Sofie Biosciences was founded in 2008 and is headquartered in Dulles, Virginia. The company has a well-established radiopharmaceutical production and distribution network and provides contract manufacturing services. In addition, Sofie Biosci...

2026-09-15

Lower Saxony, Germany Plans to Build Europe's First Large-Scale Fusion-Grade High-Temperature Superconducting Tape Plant

Proxima Fusion and the Lower Saxony state government of Germany signed a memorandum of understanding in Hanover on September 9, planning to build Europe's first large-scale fusion-grade high-temperature superconducting tape production facility in the state, laying the foundation for large-scale industrial production of high-temperature superconducting (HTS) tape. According to the plan, the first two phases of the project involve an investment of approximately 140 million euros, with public funds and private capital each covering about half. Of this, Lower Saxony plans to contribute 21 million euros, accounting for nearly 30% of the public funding portion. The first two phases of construction are expected to be completed by the end of 2029. High-temperature superconducting tape is a type of metal tape that exhibits superconducting properties at relatively higher temperatures. In the superconducting state, it can transmit current with nearly zero resistive loss and is used to manufacture high-power, compact electromagnets. For stellarator fusion devices, magnets made from high-temperature superconducting tape can generate the magnetic fields needed to confine and control high-temperature plasma, making them an important foundational material for achieving compact fusion devices and future fusion power plants.

2026-09-12

Russia and India Plan to Sign Nuclear Energy Cooperation Documents

Alexey Likhachev, Director General of the State Atomic Energy Corporation Rosatom (Rosatom), stated that Russia and India are preparing to sign a series of bilateral cooperation documents in the field of nuclear energy. The preparation of the relevant documents has reached a relatively high level of maturity and is ready for direct signing. Likhachev said that the documents to be signed involve multiple areas of cooperation, including fourth-generation nuclear energy technology using fast neutron reactors. Such cooperation will be carried out around the direction of advanced nuclear energy technology....

2026-09-12

Canada Supports IAEA "Rays of Hope" Initiative for the First Time, Will Provide Medical Isotope Training for Latin America

The Canadian Nuclear Isotope Council (CNIC) announced on September 10 that Canada has for the first time formally provided support to the International Atomic Energy Agency (IAEA) Rays of Hope initiative, and will help enhance cancer diagnosis and treatment capacity in Latin America through training in the production of medical radioisotopes and radiopharmaceuticals. The Rays of Hope initiative aims to expand access to cancer treatment and radiotherapy infrastructure in low- and middle-income countries. Under the arrangement, from November 8 to 14, 26 relevant sector leaders from Argentina, Brazil, Chile and Mexico will travel to Ontario, Canada, to participate in a training program jointly organized by Bruce Power and McMaster University. The training will focus on medical isotopes...

2026-09-11

Shanghai Jiao Tong University's "Luoshu" Ultra-Long Neutron Small-Angle Scattering Spectrometer Officially Commissioned

On September 2, the launch ceremony for Shanghai Jiao Tong University's Luoshu Ultra-Long Neutron Small-Angle Scattering Spectrometer was held at the China Mianyang Research Reactor. Yang Zhenbin, Secretary of the Party Committee of Shanghai Jiao Tong University, Huang Ming, Vice President of the China Academy of Engineering Physics, and other leaders attended the event to jointly witness the official commissioning of this major scientific research facility. At the launch ceremony, Yang Zhenbin and Huang Ming jointly lit up the Luoshu Ultra-Long Neutron Small-Angle Scattering Spectrometer, marking its official commissioning. The Luoshu spectrometer was jointly built and collaboratively developed by Shanghai Jiao Tong University and the China Mianyang Research Reactor, with multiple core indicators reaching internationally advanced levels. It can broadly support research in fields such as aerospace, nuclear power and energy, biomedicine, new materials, and basic sciences, providing...

2026-09-10

Vietnam to Join International Consortium for Russia's MBIR Fast Neutron Research Reactor

On September 9, the press service of Rosatom announced that Vietnam will join the international consortium for Russia's MBIR multi-purpose fast neutron research reactor. The reactor is currently under construction in Dimitrovgrad, Russia. Under the arrangement, the Vietnam Atomic Energy Institute (Vinatom) has been designated as Vietnam's lead organization for participation in the International Research Centre MBIR (IRC MBIR) project based on the MBIR reactor. Tran Chi Thanh, President of the Vietnam Atomic Energy Institute, stated in a declaration that participation in the project will give Vietnam more direct access to this unique experimental platform, further...

2026-09-10

US Centrus and Radiant Sign Long-Term HALEU Supply Agreement

On September 9, 2026, US nuclear fuel and services supplier Centrus Energy Corp. (Centrus) and mobile nuclear microreactor developer Radiant announced that the two parties have signed a multi-year definitive contract. Under the agreement, Centrus will supply high-assay low-enriched uranium (HALEU) fuel for Radiant's Kaleidos microreactor to support the deployment of multiple reactors. The agreement stipulates that Centrus will begin delivering HALEU by the end of this decade. The arrangement will add a domestic US fuel source for Radiant as it advances the commercial expansion of the Kaleidos reactor, and will also add a new HALEU customer for Centrus. The agreement also includes Ra...

2026-09-10

South Korea's First Animal Radiopharmaceutical Approved for the Treatment of Feline Hyperthyroidism

The Korea Atomic Energy Research Institute announced on September 10 that Thyrokitty Injection (I-131), a radiopharmaceutical for the treatment of feline hyperthyroidism developed by the research team led by Dr. Lim Jae-cheong, has obtained an animal drug manufacturing license issued by the Animal and Plant Quarantine Agency of South Korea. This is South Korea's first animal radiopharmaceutical to receive final product approval, marking the transition of related technologies that had previously been mainly at the R&D stage into clinical therapeutic application for pets. Feline hyperthyroidism is a relatively common endocrine disease in older cats, mainly characterized by excessive secretion of thyroid hormones. According to reports, approximately 10% of cats aged 10 and above may suffer from this disease. Traditional treatment methods typically require...

2026-09-10

Domestically Developed "Boron Neutron Capture Therapy System" Enters the National Special Review Procedure for Innovative Medical Devices

Recently, the Medical Device Technical Review Center of the National Medical Products Administration issued a public notice on the review results of applications for the Special Review Procedure for Innovative Medical Devices (No. 14 of 2026). The boron neutron capture therapy system independently developed by Huapeng Neutron Technology (Hangzhou) Co., Ltd. has officially entered the National Special Review Procedure for Innovative Medical Devices after the public notice period. Screenshot from the official website of the Medical Device Technical Review Center of the National Medical Products Administration. The Special Review Procedure for Innovative Medical Devices is a review channel established by the National Medical Products Administration to encourage medical device innovation and promote the application of new technologies, effective since December 1, 2018. According to the relevant procedures, drug regulatory authorities and technical institutions will, on the premise of not lowering standards and not reducing procedures,...

2026-09-10